Comment on

• Dopamine agonists and the risk of cardiac-valve regurgitation.

  Schade R, Andersohn F, Suissa S, Haverkamp W, Garbe E. Schade R, et al. N Engl J Med. 2007 Jan 4;356(1):29-38. doi: 10.1056/NEJMoa062222. N Engl J Med. 2007. PMID: 17202453
• Valvular heart disease and the use of dopamine agonists for Parkinson's disease.

  Zanettini R, Antonini A, Gatto G, Gentile R, Tesei S, Pezzoli G. Zanettini R, et al. N Engl J Med. 2007 Jan 4;356(1):39-46. doi: 10.1056/NEJMoa054830. N Engl J Med. 2007. PMID: 17202454